Loading clinical trials...
Loading clinical trials...
The study is designed to demonstrate that axitinib (AG-013736) is superior to sorafenib in delaying tumor progression in patients with metastatic renal cell cancer after failure of one first line regi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT00033137 · Kidney Neoplasms, Kidney Cancer, and more
NCT07225114 · Breast Cancer, Kidney Neoplasms, and more
NCT06680089 · Urologic Neoplasms, Urogenital Neoplasms, and more
NCT05917106 · Carcinoma, Renal Cell Carcinoma, and more
NCT06536439 · Kidney Cancer, Kidney Neoplasms, and more
East Valley Hematology and Oncology Medical Group
Burbank, California
Maurice Berkowtiz, MD
Burbank, California
Agajanian Institute of Oncology and Hematology
Downey, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions